Welcome to our dedicated page for Cno Finl Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CNO Financial Group filings document the insurance holding company's operating results, governance and capital actions. Form 8-K reports furnish quarterly financial results, financial supplements and operating presentations covering life and health insurance, annuities, distribution activity, investment results and capital management.
Proxy and governance filings address annual meeting voting items, director elections, board committee matters, executive compensation and director compensation. Other material-event reports disclose dividend declarations, board appointments or retirements, Regulation FD presentations and securities identified in the company's capital structure.
CNO Financial insider Gary Bhojwani filed a notice to sell 45,357 shares of CNO common stock under Rule 144. The planned sale, through Morgan Stanley Smith Barney on the NYSE around 02/17/2026, has an aggregate market value of 1957866.65.
The shares to be sold are performance shares of common stock acquired from the issuer on 02/10/2026. In the past three months, Bhojwanii also sold 31,430 common shares on 01/02/2026 for gross proceeds of 1319641.98 and 31,430 shares on 11/20/2025 for 1256222.53.
CNO Financial Group insider Yvonne K. Franzese has filed a Form 144 indicating an intention to sell 9,000 shares of CNO common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $388,556.70 and an approximate sale date of February 17, 2026 on the NYSE.
The notice shows these 9,000 shares were acquired as performance shares from the issuer on February 10, 2026. It also discloses a prior sale of 3,000 common shares on November 24, 2025 for gross proceeds of $123,000. Shares outstanding were 95,353,512 as of the filing, which is a baseline figure, not the amount being sold.
By signing the notice, the seller represents that they do not know of any material adverse, nonpublic information about CNO’s operations, and acknowledges the additional representation required if relying on a Rule 10b5-1 trading plan.
CNO Financial Group executive Scott L. Goldberg reported equity award activity. On February 10, 2026, he acquired 26,071 shares of common stock at $43.05 per share upon vesting of performance share units tied to 2023 operating return on equity, 2023 operating earnings per share, and three-year relative total shareholder return for 2023-2025.
On the same date, 8,185 common shares were surrendered to CNO to cover required tax withholding on the vested performance share units, leaving 198,724 common shares beneficially owned directly. Goldberg also received 15,800 restricted stock units at $0 per unit, which convert into common stock on a one-for-one basis and vest in three equal annual installments beginning March 25, 2027, bringing his directly held restricted stock units to 214,524.
CNO Financial Group’s President, Consumer Division reported an amended insider transaction. On February 10, 2023, the officer exercised employee stock options for 17,095 shares of common stock at $16.42 per share, then sold 17,095 shares at a weighted average price of $25.3397 under a Rule 10b5-1 trading plan adopted on November 11, 2022. Following these transactions, the officer directly beneficially owned 137,305 shares of CNO common stock. The amendment also corrects the presentation of the option exercise and the post-transaction share balance, and notes the options had vested on February 25, 2018 and were scheduled to expire on February 25, 2025.
CNO Financial Group Chief Executive Officer and director Gary C. Bhojwani reported equity compensation activity. On February 10, 2026, he acquired 152,542 shares of common stock at $43.05 per share upon vesting of performance share units tied to 2023–2025 performance metrics.
On the same date, 64,164 shares of common stock were disposed of at $43.05 per share to satisfy required tax withholding on the vested performance share units. He also received a grant of 81,600 restricted stock units at no cost, which convert one-for-one into common stock and vest in three equal annual installments beginning March 25, 2027, subject to continued employment.
CNO Financial Group General Counsel Matthew J. Zimpfer reported multiple equity award transactions. On February 10, 2026, he acquired 25,384 shares of common stock upon vesting of performance share units and surrendered 7,663 shares to cover tax withholding. He also received 14,300 restricted stock units, which convert one-for-one into common stock and vest in three equal annual installments beginning March 25, 2027.
On February 12, 2026, he exercised an employee stock option for 30,970 shares at an exercise price of $21.06 per share, then sold 30,970 shares of common stock at a weighted average price of $42.9313 per share under a pre-established Rule 10b5-1 trading plan. After these transactions, he directly owned 307,937 shares of common stock.
CNO Financial Group officer Karen J. DeToro, President of the Worksite Division, reported equity compensation changes. On February 10, 2026, she acquired 13,835 shares of common stock at $43.05 per share upon vesting of performance share units tied to 2023–2025 operating and shareholder return metrics.
On the same date, 6,135 shares were surrendered back to CNO Financial at $43.05 per share to cover required tax withholding on the vested performance share units. She also received a grant of 7,900 restricted stock units at $0, which convert one-for-one into common stock and vest in three equal annual installments beginning on March 25, 2027, subject to continued employment.
CNO Financial Group’s Chief Human Resources Officer, Yvonne K. Franzese, reported equity compensation activity. On 02/10/2026 she acquired 19,210 shares of common stock upon vesting of performance share units tied to 2023–2025 operating and shareholder return metrics, and 7,090 shares were surrendered back to the company to satisfy tax withholding.
Franzese also received a new grant of 10,800 restricted stock units, which convert into common stock on a one-for-one basis and vest in three equal annual installments beginning March 25, 2027, subject to continued employment. After these transactions she directly holds 33,262 common shares and 44,062 RSUs, and indirectly holds 78,279 common shares through the Yvonne K. Franzese Revocable Trust.
CNO Financial Group’s Chief Investment Officer Eric R. Johnson reported equity compensation activity on common stock. On February 10, 2026, he acquired 25,384 shares of common stock at $43.05 per share upon vesting of performance share units tied to 2023–2025 performance metrics.
On the same date, he disposed of 11,373 shares at $43.05 by surrendering them to the company to cover required tax withholding on the vested units. He also received a grant of 15,300 restricted stock units at $0, which convert into common stock on a one-for-one basis.
Following these transactions, Johnson directly owns 684,969 shares of common stock and holds 700,269 restricted stock units. The new restricted stock units vest in three equal annual installments beginning on March 25, 2027, subject to continued employment with CNO Financial Group or its subsidiaries.
CNO Financial Group Chief Accounting Officer Joel T. Koehneman received a grant of 2,100 restricted stock units on February 10, 2026. These units were awarded at a price of $0 per unit and increased his directly held restricted stock unit balance to 5,292.
The restricted stock units convert into common stock on a one-for-one basis. They vest in three equal annual installments beginning March 25, 2027, as long as Koehneman remains employed by CNO Financial Group or one of its subsidiaries.